tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Ownership - Who Owns Relay Therapeutics?

Compare
455 Followers

Relay Therapeutics (RLAY) Ownership Overview

2.91%16.98%48.39%15.28%16.43%
48.39% Other Institutional Investors
15.28% ETFs
16.43% Public Companies and
Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 80.65% of the company’s stock is owned by Institutional Investors, 2.91% is owned by Insiders, and 16.43% is owned by Public Companies and Individual Investors.
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 65.37% of the company’s stock is owned by Institutional Investors, 2.91% is owned by Insiders, and 15.28% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 13, 2025
Sanjiv Patel
President & Ceo,director
xxxxxxxxxxxxx
$818400
Jan 30, 2025
xxxxxxxxxxxxx
$248173
Jan 30, 2025
xxxxxxxxxxxxx
$247872
Jan 30, 2025
Donald A Bergstrom
President, R&d
xxxxxxxxxxxxx
$362298

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$91979
Dec 31, 2024
xxxxxxxxxxxxx
$130064

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
14,346,224Institution8.46%50,355,246
13,152,743Institution7.76%46,166,128
6,001,355Institution3.54%21,064,756
2,841,382Institution1.68%9,973,251
2,682,083Institution1.58%9,414,111
1,769,992Insider1.04%6,212,672
1,382,939Institution0.82%4,854,116
1,299,567Institution0.77%4,561,480
1,160,117Institution0.68%4,072,011
1,154,040Institution0.68%4,050,680

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,152,743Institution7.76%46,166,128
2,682,083Institution1.58%9,414,111
1,382,939Institution0.82%4,854,116
1,299,567Institution0.77%4,561,480
1,154,040Institution0.68%4,050,680
1,120,018Institution0.66%3,931,263
1,028,869Institution0.61%3,611,330
853,200Institution0.50%2,994,732
750,947Institution0.44%2,635,824
701,703Institution0.41%2,462,978

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,989,680Institution2.94%17,014,809
4,049,434Institution2.39%16,683,668
3,356,666Institution1.98%12,285,398
2,606,945Institution1.54%8,889,682
2,293,995Institution1.35%10,254,158
1,956,353Institution1.15%6,671,164
1,128,269Institution0.67%4,129,465
740,785Institution0.44%2,711,273
606,483Institution0.36%2,068,107
561,589Institution0.33%1,915,018

FAQ

Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 48.39% of the company's stock is held by institutional investors, 2.91% is held by insiders, and 16.43% is held by retail investors.
    What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 48.39% of Relay Therapeutics (RLAY) stock is held by institutional investors.
      What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
      According to the latest TipRanks data, approximately 16.43% of Relay Therapeutics (RLAY) stock is held by retail investors.
        Who owns the most shares of Relay Therapeutics (RLAY)?
        Vanguard owns the most shares of Relay Therapeutics (RLAY).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis